GRN mutations in symptomatic and presymptomatic carriers were linked to reduced PGRN levels in blood in relation to HC, presymptomatic carriers of other mutations (C9orf72, MAPT), and patients with FTD. The gene discussed is GRN; the disease is frontotemporal dementia.